Autism Stem Cell Therapy Abroad: A Guide for Families in the Netherlands & UAE
How families in the Netherlands and the United Arab Emirates can explore mesenchymal stem cell therapy for autism abroad — with honest context on regulation at home, travel logistics, cost, and coordination with your existing care team.
Why Families in the Netherlands and UAE Look Abroad
Families raising a child on the autism spectrum in the Netherlands and the United Arab Emirates share a common experience: excellent local support for behavioural and developmental therapy, but no locally approved cell-based biological intervention. In the Netherlands, care is anchored in evidence-based behavioural approaches, speech and language therapy, and multidisciplinary support coordinated through the GGZ mental-health system and paediatric centres. In the UAE, families in Dubai and Abu Dhabi access a fast-growing network of private developmental clinics, ABA providers, and international schools with strong special-education programmes.
What neither system currently offers as a routine, reimbursed pathway is mesenchymal stem cell (MSC) therapy. Because of this, a subset of well-informed parents research treatment abroad. StemCell Longevita operates as an international patient coordination platform based in Istanbul, Turkey — we are not a treatment provider and we do not diagnose autism or promise a cure. Our role is to help families understand what MSC therapy is, whether their child may be a reasonable candidate, and to coordinate the logistics of accessing GMP-standard care at a partner hospital, while keeping your home care team informed.
This guide is written specifically for the Dutch and Emirati context — the regulation you live under, the travel realities from Schiphol or Dubai International, the way costs compare, and how a treatment episode abroad can be woven into the behavioural and developmental programme your child already follows at home.
The Regulatory Picture at Home
Understanding why the pathway differs in the Netherlands and the UAE helps families make an informed, realistic decision.
Netherlands (EU/EMA)
Stem cell products are regulated as Advanced Therapy Medicinal Products under EMA rules. No MSC product is approved for autism, so it is not offered or reimbursed within Dutch healthcare. Treatment abroad is a personal, out-of-pocket choice.
United Arab Emirates
The UAE has invested heavily in regenerative medicine and cell therapy research, but autism is not an approved indication. Families typically travel for treatment while continuing their developmental programme at home in Dubai or Abu Dhabi.
Turkey's Framework
Turkey regulates cell therapy through its Ministry of Health, with GMP-certified processing standards. MSC therapy for autism is offered within a clearly defined, individually-assessed, non-curative supportive framework.
Honest Positioning
No credible provider anywhere claims MSC therapy cures autism. The evidence base is early-stage. It should be considered a supportive, adjunctive option — never a replacement for behavioural and developmental therapy.
What MSC Therapy Does — and Does Not — Claim
Mesenchymal stem cell therapy in the context of autism is being studied for its immunomodulatory and anti-inflammatory properties. A body of early research explores the observation that a subset of children on the spectrum show markers of chronic neuroinflammation and immune dysregulation. The hypothesis under investigation is that MSCs, through the signalling molecules they secrete, may help modulate this inflammatory environment. This is a research-stage hypothesis, not established medical fact.
It is essential to be clear about what this means for a Dutch or Emirati family. MSC therapy does not 'cure' autism, does not change a child's fundamental neurology, and results reported in early studies vary widely between individuals. Some families report improvements in areas such as sleep, attention, gastrointestinal comfort, or social engagement; others report no measurable change. Any provider guaranteeing specific outcomes should be treated with caution.
Our coordination role includes making sure you receive this honest framing before you travel. We provide the published evidence, the realistic range of outcomes, and a candid assessment of whether your child's profile aligns with the cases most studied — so your decision is genuinely informed rather than driven by hope alone.
The Coordinated Patient Journey
From your first enquiry in the Netherlands or UAE to follow-up back home, coordination happens in structured stages.
1. Remote Case Review
You share your child's diagnosis, developmental reports, and medical history securely. A medical team reviews suitability before anything is booked — many enquiries are advised that treatment is not appropriate.
2. Consultation in Your Language
Consultations are available in English and Dutch, with Arabic-speaking coordination support for UAE families, so nothing is lost in translation.
3. Travel & Treatment Window
A typical stay in Istanbul is 4–6 days, timed around school holidays where possible to minimise disruption for your child.
4. Treatment Episode
Care is delivered at a JCI-accredited partner hospital using GMP-processed cells, with paediatric-appropriate monitoring throughout.
5. Structured Follow-Up
A 12-month telemedicine follow-up plan keeps your home paediatrician and therapists informed of what was done and what to watch for.
6. Family Support
You are supported by a single coordinator throughout, rather than passed between departments — important when travelling with a child who needs routine.
Travel Logistics from Amsterdam, Dubai & Abu Dhabi
Istanbul is unusually convenient for both regions, which is part of why it has become a hub for coordinated care. Practical planning matters most when travelling with a child on the spectrum, so logistics are arranged with sensory and routine needs in mind.
From the Netherlands
- Direct flights Amsterdam (AMS) to Istanbul (IST): approximately 3.5 hours
- No visa required for Dutch citizens for short medical stays
- Same time zone in winter; one hour ahead in summer — minimal jet lag for children
- English and Dutch-speaking coordination throughout the stay
- Quiet airport transfer and family-suitable accommodation arranged in advance
From the UAE
- Direct flights Dubai (DXB) & Abu Dhabi (AUH) to Istanbul: approximately 4.5 hours
- Straightforward entry arrangements for UAE residents and citizens
- One hour behind UAE time — easy adjustment for young children
- Arabic-speaking coordination support available
- Halal dining and family accommodation options arranged on request
Cost Compared to Staying Home
Indicative figures only — every case is individually quoted after review. These illustrate why coordinated treatment in Istanbul is a consideration for families weighing options.
Working With Your Local Team
MSC therapy should complement — never replace — the behavioural and developmental programme your child follows in the Netherlands or UAE.
Is Your Child a Candidate?
Careful selection matters. Not every child who enquires is suitable, and we will say so honestly.
Frequently Asked Questions
Related Stem Cell Treatments
Explore Care Coordination for Your Country
التنسيق الدولي للمرضى
تعمل StemCell Longevita كمنصة تنسيق دولية للمرضى. نربط المرضى بالمؤسسات الطبية المرخصة التي تقدم تطبيقات الطب التجديدي بعد تقييم الطبيب وضمن الأطر التنظيمية المعمول بها. جميع القرارات والإجراءات الطبية يتم اتخاذها حصرياً من قبل متخصصين صحيين مرخصين. StemCell Longevita لا تقدم علاجاً طبياً مباشراً.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as medical advice. Stem cell therapy is an evolving field, and outcomes may vary by individual. The treatments described on this site have not been fully evaluated or approved by the FDA or equivalent regulatory bodies in all jurisdictions.
The FDA has not approved stem cell applications for most conditions listed on this website. Results mentioned are based on clinical observations, published research, and patient-reported outcomes. Individual results may vary and no specific outcomes are assured for any individual patient.
إدراج المنشورات العلمية على هذا الموقع لا يعني الموافقة التنظيمية أو نتائج سريرية مضمونة. قد تُعتبر بعض التطبيقات تجريبية حسب الاستطباب والاختصاص القضائي.
Always consult with a qualified healthcare professional before making any medical decisions. Do not disregard professional medical advice or delay seeking treatment based on information found on this website.